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Objective: To gain ‘first-in-man’ evidence that repeated caloric vestibular stimulation 
(CVS), a non-invasive form of neuro-modulation, can induce a lasting and clinically-
relevant reduction in Parkinson’s Disease (PD) symptoms.  
 
Methods: A 70yr old male, diagnosed with PD 7 years prior to study enrolment, self-
administered CVS at home 2x20 minutes per day for three months using a solid-state 
portable device. Standardised neuropsychological assessments of motor, cognitive, 
affective and independent function were carried out prior to stimulation, at the start 
and end of the sham (month 1) and active (months 2-3) phases, and 5 months post-
stimulation. 
 
Results: Relative to the pre-stimulation baseline, behavioural improvements that 
exceeded the minimal detectable change were observed on the EQ5D, Unified 
Parkinson’s Disease Rating Scale, Schwab and England scale, 2 minute walk, Timed 
up and go, Non-motor symptom assessment scale for PD, Montreal cognitive 
assessment, Hospital depression scale and Epworth sleepiness scale. The level of 
change exceeded the threshold for a minimal clinically important difference on all 
scales for which a threshold has been published. By contrast, little improvement was 
seen during the sham (i.e. placebo) phase. 
 
Conclusion: Caloric vestibular stimulation may offer a novel, home-based method of 




The vestibular system detects linear, angular and gravitational acceleration of the 
head and plays an important role in the autonomic control of eye movement, posture, 
gait and egocentric perception (see Smith & Zheng, 2013). Artificial stimulation of 
the peripheral balance organs, via either galvanic or thermal current, up-regulates 
metabolic activity across a range of cortical, striatal and cerebellar brain areas (Lopez, 
Blanke & Mast, 2012). The clinical relevance of this metabolic activity has been 
demonstrated in a number of acquired neurological conditions including hemi-spatial 
neglect (Wilkinson et al., 2014), aphasia (Wilkinson, Morris, Milberg & Sakel, 2013), 
mania (Levine et al., 2012), central pain (McGeoch, Williams, Lee & Ramachandran, 
2008) and post-stroke postural instability (Sturt & Punt, 2013). Despite these 
promising results, comparably little investigation has been conducted with individuals 
who suffer from neuro-degenerative disease. 
Recent study has, however, produced growing theoretical interest in the idea 
that ascending projections from the vestibular brainstem nuclei may provide a 
therapeutic pathway in Parkinson’s Disease (PD). In a recent hemi-parkinsonian rat 
study, artificial stimulation of the vestibular nerves via transmastodial galvanic 
current was associated with improved locomotory ability and allied increases in 
GABA concentration in substantia nigra pars reticulata (Samoudi, Nissbrandt, Dutia 
& Bergquist, 2012). In human PD studies, galvanic vestibular stimulation has been 
shown to spontaneously reduce postural sway (Pal, Rosengren & Colebatch, 2009), 
postural response time (Samoudi, Jivegård, Mulavara, & Bergquist, 2015) and also 
lead to a quickening of bradykinesic rest-to-active transitions in the wrist and trunk 
(Pan, Soma, Yamamoto, 2008). Although these results demonstrate the potential 
therapeutic value of vestibular stimulation in PD, they were acquired under highly 
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prescribed, controlled laboratory conditions, utilized a narrow range of mostly 
experimental rather than clinical outcomes, and perhaps most importantly did not 
show if the effects persisted beyond a few hours. In this brief report, we provide the 
first evidence, drawn from a single-case study, that repeated sessions of vestibular 
stimulation can induce durable, clinically meaningful improvements in both the motor 
and non-motor symptoms of PD.  
 
Participant 
The participant, a male, aged 70yrs, was diagnosed with PD 7years prior to study 
enrolment. At study screening, his predominant symptoms were hypokinesia, rigidity 
and memory loss although formal testing revealed a far broader range of motor and 
cognitive difficulties – see baseline data in Table 1. His medication (stalevo 
150mg/25mg/200mg, levodopa 100mg with carbidopa 25mg and entacapone 200mg 
tablets 3 times per day; pramipexole dihydrochloride 1mg tablets 3 times per day) 
remained unchanged throughout the study. 
 
Intervention 
Vestibular stimulation was induced using a novel, caloric device (Scion Neurostim) 
comprising a headset fashioned like music headphones with aluminum earpieces that 
contained a solid-state heater/cooler element which warmed and cooled the external 
ear canals via controlled, time-varying thermal waveforms (see Figure 1).  One 
earpiece delivered a cold sawtooth waveform (ear canal temperature to 170C every 
2mins) and the other delivered a warm sawtooth  (ear canal temperature to 420C every 
1 minute). To ensure balanced hemispheric activation over the course of the study 
(warm currents primarily activate ipsilateral cortex while cold currents primarily 
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activate contralateral cortex) we switched the waveform assigned to each ear every 2 
days. Each stimulation session lasted 20mins during which time the patient lay 
passively supine with his head resting on a wedge-shaped pillow angled at 300. Two 
sessions, spaced at least 4hrs apart, were administered by the patient (with the help of 
his wife) twice per day, 5 days per week for 3 months. Sham stimulation was 
delivered in the first month, followed by 2 months of active stimulation. In the sham 
condition, the unit was operated in the same way as in the active condition, but no 
power was delivered to the earpieces. The patient was informed that various doses 
would be administered over the 3 months, and that although there may be times when 
temperature changes could be felt in the ear (i.e. in the active condition), this should 
not be taken as evidence that the device was now any more or less effective.  
Following institutional ethics approval and the patient’s informed consent, 
standardised clinical outcome measures with high test-retest reliability and sensitive 
to both motor (Unified Parkinson’s Disease Rating Motor sub-scale; 2 minute Walk, 
Timed up and go) and non-motor symptoms (Unified Parkinson’s Disease Rating 
ADL sub-scale, Non-motor symptom assessment scale, Montreal cognitive 
assessment, Epworth sleepiness scale, fatigue severity scale) and more general well-
being and functional capacity (Schwab and England scale, Hospital anxiety and 
depression scales, EQ5D) were administered in random order 2 weeks prior to sham 
stimulation, at the end of the 4 week sham block, at the end of the 1st and 2nd active 
months, and then at 5 months follow-up after stimulation. 
Figure 1 about here 
Results 
As can be seen in Table 1, improvement was observed across nearly all measures 
during the active relative to sham phase; mobility and cognition increased 
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dramatically and the patient reported feeling less anxious and able to sleep better. 
Consistent with a cumulative effect, the greatest improvement was typically observed 
during the second month of active stimulation, and was still evident at 5months 
follow-up. These improvements were too large to attribute to published measurement 
error and exceeded the statistical criterion for minimal clinically important change 
(MCID) on the UPDRS motor and ADL sub-scales, Schwab & England ADL scale, 
and HADS depression scale (MCID criteria were unavailable for the other tests).  
 
Table 1 here 
Discussion 
The favorable outcome in this individual could in theory be explained by coincident 
change unrelated to the intervention, however both the consistency and scale of 
change and the fact that it was time-locked to the transition from sham to active 
stimulation makes this less likely. Although the individual was led to believe that 
thermal sensations in his ear should not be taken as evidence that the stimulation was 
now somehow more effective, it is conceivable that the sensation uniquely associated 
with active stimulation improved his behavioural performance via psychological (i.e. 
placebo-based), as opposed to neurological, means. It is, however, difficult to believe 
that an improvement of this origin would still be evident at both formal assessment 
and from relatives’ testimony 5months later. In line with previous study (Samoudi et 
al., 2012, 2015), we therefore tentatively attribute the effects to a vestibular-based 
mechanism.  
As highlighted by Benninger and Hallett (2015), the shortcomings of 
conventional pharmacological therapy coupled with the recent success of deep brain 
stimulation in advanced PD has raised interest in non-invasive forms of neuro- 
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stimulation, however, there has so far been little evidence from transcranial studies 
that the reported gains translate to long-lasting improvements in well-being and 
functional independence. We recognize that the inferential power of the present 
single-case study is limited, however, the improved response profile demonstrated by 
the participant, perhaps most notably at 5months follow-up, alludes to a practical 
patient benefit that, in our opinion, justifies larger-scale investigation. Although the 
biological basis of recovery was not investigated here, we speculate that the non-
motor gains point to activation of non-dopaminergic pathways and may underline the 
growing therapeutic relevance of the pedunculopontine nucleus given that it both 
sends and receives dense projections from areas with known vestibular responses and, 
when directly activated via deep brain stimulation, has been associated with 
heightened cognition and arousal (Ballanger et al., 2009).  
Finally, we note that the potential of CVS to help treat cognitive and motor 
dysfunction in both acquired and dementing neurological illnesses has long been 
discussed, however, widespread investigation has been hampered by the reliance on 
cold-water irrigation of the external ear canal which induces nausea and dizziness and 
is unsuited for repeated administration. Recent advances in biomedical engineering 
have, however, led to the development of home-use, solid-state devices which enable 
the temperature of the waveform to be both varied and tightly controlled which in turn 
offsets physiological habituation and allows the temperature to be maintained at or 
above 150C. This temperature is too mild to induce distracting side-effects but is the 
approximate point at which the vestibular nerves reach asymptote  (Reker, 1977). 
These technical developments have enabled CVS to become a tool that is potentially 
relevant to the management of PD and, given the data reported here, should motivate 
investigations that move beyond single-case and small-group designs.  
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 Baseline Sham Active 1 Active 2 Follow-up 
EQ5D      
   mobility 2 2 2 2 2 
   self-care 2 2 2 2 2 
   usual activities 2 2 2 2 2 
   pain/discomfort 2 2 2 1*§ 1§ 
   anxiety/depression 2 2 1§ 1§ 1§ 
UPDRS      
   total 85 79* 57§ 41*§ 55§ 
   subscale I 7 6 6 4*§ 1*§ 
   subscale II  24 24 17§ 12*§ 15§ 
   subscale III  54 49* 34§ 25*§ 39§ 
Schwab and England (%) 64 65 64 72*§ 70§ 
2minute walk (meters) 22 36 84§ 120*§ 102§ 
Timed up and go (secs) 20.4 23 21.5 16.2*§ 13.3§ 
NMSS 109 108 101 49*§ 58§ 
MoCA 12 12 14 21*§ 20§ 
HADS      
   depression 11 11 5§ 5§ 4§ 
   anxiety 4 4 2 0 0 
ESS 16 15* 18 8*§ 7*§ 
FSS 5.2 5.4 4.4 4.1 4.2 
 
Abbreviations: *exceeds minimal detectable change (MDC) from preceding score; 
§exceeds MDC from sham score. UPDRS=Unified Parkinson’s Disease rating scale; 
NMSS=Non-motor symptom assessment scale for Parkinson’s Disease; 
MOCA=Montreal cognitive assessment; HADS=Hospital anxiety and depression 
scale; ESS=Epworth sleepiness scale; FSS=Fatigue severity scale of sleep disorders. 
 




Figure 1. Schematic of the headset and hand-held user interface of the thermo neuro-
modulation unit used to deliver caloric vestibular stimulation. 
 13 
 
 
 
 
 
 
Figure 2 
Figure 1.!
 
 
Figure 1 
 
 
 
 
 
 
  
